Epigenetic silencing of antiviral genes renders clones of Huh-7 cells permissive for hepatitis C virus replication

Journal of Virology

Volumn 87, Issue 1, 2013, Pages 659-665

  Chen, Qiuyue ^a   Denard, Bray ^a   Huang, Hua ^a,b   Ye, Jin ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; CYCLIC AMP RESPONSE ELEMENT BINDING PROTEIN 3 LIKE 1 GENE; DNA METHYLATION; EPIGENETICS; GENE; GENE SILENCING; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MYXOVIRUS RESISTANT 1 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS REPLICATION;

CELL LINE; EPIGENESIS, GENETIC; GENE SILENCING; GTP-BINDING PROTEINS; HEPACIVIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRUS REPLICATION;

HEPATITIS C VIRUS; ORTHOMYXOVIRIDAE;

EID: 84871946952     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01984-12     Document Type: Article

References (21)

1. Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113.
2. Blight KJ, McKeating JA, Rice CM. 2002. Highly permissive cell lines for hepatitis C virus genomic and subgenomic RNA replication. J. Virol. 76: 13001-13014.
3. Sumpter R, Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M, Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699.
4. Binder M, Kochs G, Bartenschlager R, Lohmann V. 2007. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 46:1365-1374.
5. Denard B, Seemann J, Chen Q, Gay A, Huang H, Chen Y, Ye J. 2011. The membrane-bound transcription factor CREB3L1 is activated in response to virus infection to inhibit proliferation of virus-infected cells. Cell Host Microbe 10:65-74.
6. Pietschmann T, Lohmann V, Rutter G, Kurpanek K, Bartenschlager R. 2001. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J. Virol. 75:1252-1264.
7. Scholle F, Li K, Bodola F, Ikeda M, Luxon BA, Lemon SM. 2004. Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis. J. Virol. 78:1513-1524.
8. Deaton AM, Bird A. 2011. CpG islands and the regulation of transcription. Genes Dev. 25:1010-1022.
9. Cai Z, Zhang C, Chang KS, Jiang J, Ahn BC, Wakita T, Liang TJ, Luo G. 2005. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J. Virol. 79:13963- 13973.
10. Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M, Jr, Ye J. 2007. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 104:5848-5853.
11. Sumpter R, Jr, Wang C, Foy E, Loo YM, Gale M, Jr. 2004. Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model. J. Virol. 78:11591-11604.
12. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. 2002. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory elementbinding protein-1c. J. Biol. Chem. 277:9520-9528.
13. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL. 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. U. S. A. 100:12027-12032.
14. Christman JK. 2002. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21:5483-5495.
15. Fensterl V, Sen GC. 2011. The ISG56/IFIT1 gene family. J. Interferon Cytokine Res. 31:71-78.
16. Haller O, Staeheli P, Kochs G. 2006. Interferon-induced Mx proteins in antiviral host defense. Biochimie 89:812- 818.
17. Calmon MF, Rodrigues RV, Kaneto CM, Moura RP, Silva SD, Mota LD. 2009. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia 11:1329-1339.
18. Desmond JC, Raynaud S, Tung E, Hofmann WK, Haferlach T, Koeffler HP. 2007. Discovery of epigenetically silenced genes in acute myeloid leukemias. Leukemia 21:1026-1034.
19. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. 2005. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37:853- 862.
20. Naka K, Ki. Abe Takemoto K, Dansako H, Ikeda M, Shimotohno K, Kato N. 2006. Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cells. J. Hepatol. 44:869-878.
21. Frese M, Pietschmann T, Moradpour D, Haller O, Bartenschlager R. 2001. Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J. Gen. Virol. 82:723-733.